ADAM10 and head and neck squamous cell carcinoma: Concerning the results from TCGA, the ADAM‐10 mRNA level was significantly higher in the HNSCC group than the control group (p < 0.0001) (Figure 1A) and associated with lower 5‐year survival rate of HNSCC (p = 0.008) (Figure 1B).